Olivia S. Costa

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity

Alix F. Leblanc, Jason A. Sprowl, Paola Alberti et al. · Journal of Clinical Investigation · 2018 · 78 citations · Full text

Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis

Olivia S. Costa, Stuart J. Connolly, Mukul Sharma et al. · Critical Care · 2022 · 66 citations · Full text

Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data

Olivia S. Costa, Jan Beyer‐Westendorf, Veronica Ashton et al. · Current Medical Research and Opinion · 2020 · 33 citations · Full text

Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data

Olivia S. Costa, Jan Beyer‐Westendorf, Veronica Ashton et al. · Journal of Thrombosis and Thrombolysis · 2020 · 31 citations

Thrombosis, Pulmonary Embolism, Venous Thrombosis +13

Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism

Olivia S. Costa, Christine G. Kohn, Nicole M. Kuderer et al. · Blood Advances · 2020 · 22 citations · Full text